Development of freeze-dried kit for the preparation of [۹۹mTc]Tc-HYNIC-ALUG: A potential agent for imaging of prostate specific membrane antigen

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 212

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IRJNM-32-2_005

تاریخ نمایه سازی: 17 تیر 1403

چکیده مقاله:

Introduction: Prostate-specific membrane antigen (PSMA) is increasingly recognized as a viable target for imaging and therapy of Prostate cancer (PCa). In this study, we introduce the freeze-dried kit formulation of [۹۹mTc]Tc-HYNICALUG for easy clinical evaluation of prostate cancer.Methods: In this work, an in silico modeling of the urea-based PSMA small molecule (HYNIC-ALUG) was performed to check its interaction with human glutamate carboxypeptidase II and compared it with experimental results. The HYNIC-PSMA kit was formulated for easy preparation of [۹۹mTc]Tc-HYNIC-ALUG. The kit contained a freeze-dried mixture of HYNIC-ALUG, coligands SnCl۲.۲H۲O, and antioxidant D-mannitol.Results: The calculated Ki value (inhibition/dissociation constant) was ۴.۵۵ which showed excellent binding affinity of HYNIC-ALUG with PSMA.  miLogP and cLogS values are -۴.۰۴ and -۳.۰۷ respectively showing its hydrophilic character and predicting its excellent distribution in biological fluids.  Subsequently, the radiochemical purity of the HYNIC-PSMA kit was ۹۹.۱ ± ۱.۳۲% (n = ۶) determined by radio-ITLC and by HPLC as well. In vitro stability in saline and serum was studied up to ۴ h and showed high stability (≥ ۹۶%). The distribution of [۹۹mTc]Tc-HYNIC-ALUG was carried out in two patients and SPECT/CT planar images were acquired at ۲h and ۴h respectively. Bio-physiological distribution of [۹۹mTc]Tc-HYNIC-ALUG was observed normally in lacrimal, salivary glands, liver, spleen, gut, kidneys, and urinary bladder.Conclusion: The HYNIC-ALUG freeze-dried kit could be used for easy preparation of [۹۹mTc]Tc-HYNIC-ALUG and can be considered as a potential agent for the diagnosis, staging, and restaging of advanced prostate cancer.

نویسندگان

Tanveer Bokhari

Department of Chemistry, Government College University, Faisalabad, Pakistan

Fehmida Bibi

Department of Chemistry, Government College University, Faisalabad, Pakistan

Muhammad Irfan

Isotope Production Division, Pakistan Institute of Nuclear Science and Technology, Nilore, Islamabad, Pakistan

Faiz Ahmed

Department of Chemistry, Government College University, Faisalabad, Pakistan

Talal Rahman

Karachi Institute of Radiotherapy and Nuclear Medicine, Karachi, Pakistan

Shazia Fatima

Karachi Institute of Radiotherapy and Nuclear Medicine, Karachi, Pakistan

Muhammad Zeeshan

Department of Chemistry, Government College University, Faisalabad, Pakistan

Maria Hassan

Department of Chemistry, Government College University, Faisalabad, Pakistan

Adam Ullah

Department of Chemistry, Government College University, Faisalabad, Pakistan

Muhammad Wasim

Isotope Production Division, Pakistan Institute of Nuclear Science and Technology, Nilore, Islamabad, Pakistan

Nadeem Lodhi

Isotope Production Division, Pakistan Institute of Nuclear Science and Technology, Nilore, Islamabad, Pakistan

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Osdzich P, Darr C, Hilser T, Wahl M, Herrmann K, ...
  • Xia C, Dong X, Li H, Cao M, Sun D, ...
  • Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, ...
  • Maurer T, Eiber M, Schwaiger M, Gschwend JE. Current use ...
  • Bryant RJ, Hamdy FC. Screening for prostate cancer: an update. ...
  • Sharifi M, Yousefnia H, Bahrami-Samani A, Jalilian AR, Zolghadri S, ...
  • Santoni M, Scarpelli M, Mazzucchelli R, Lopez-Beltran A, Cheng L, ...
  • Brunello S, Salvarese N, Carpanese D, Gobbi C, Melendez-Alafort L, ...
  • Ferro-Flores G, Luna-Gutiérrez M, Ocampo-García B, Santos-Cuevas C, Azorín-Vega E, ...
  • Garnuszek P, Karczmarczyk U, Maurin M, Sikora A, Zaborniak J, ...
  • Xu X, Zhang J, Hu S, He S, Bao X, ...
  • Werner RA, Derlin T, Lapa C, Sheikbahaei S, Higuchi T, ...
  • Jacobson O, Kiesewetter DO, Chen X. Fluorine-۱۸ radiochemistry, labeling strategies ...
  • Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, ...
  • Lawal IO, Ankrah AO, Mokgoro NP, Vorster M, Maes A, ...
  • Boschi A, Uccelli L, Martini P. A picture of modern ...
  • Rezazadeh F, Sadeghzadeh N. Tumor targeting with ۹۹m Tc radiolabeled peptides: Clinical ...
  • Lebowitz E, Richards P. Radionuclide generator systems. Semin Nucl Med. ...
  • Nairne J, Iveson PB, Meijer A. Imaging in drug development. ...
  • Urbán S, Meyer C, Dahlbom M, Farkas I, Sipka G, ...
  • Kim MH, Kim SG, Kim DW. Dual-labeled prostate-specific membrane antigen ...
  • Rathke H, Afshar-Oromieh A, Giesel FL, Kremer C, Flechsig P, ...
  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, ...
  • Liu C, Zhu Y, Su H, Xu X, Zhang Y, ...
  • Decristoforo C, Mather SJ. The influence of chelator on the ...
  • Shaghaghi Z, Abedi SM, Hosseinimehr SJ. Tricine co-ligand improved the ...
  • Maurer T, Eiber M, Schwaiger M, Gschwend JE. Current use ...
  • Decristoforo C, Mather SJ. ۹۹m-Technetium-labelled peptide-HYNIC conjugates: effects of lipophilicity ...
  • Hubalewska-Dydejczyk A, Fröss-Baron K, Mikołajczak R, Maecke HR, Huszno B, ...
  • King R, Surfraz MB, Finucane C, Biagini SC, Blower PJ, ...
  • Xu X, Zhang J, Hu S, He S, Bao X, ...
  • Hadisi M, Vosoughi N, Yousefnia H, Bahrami-Samani A, Zolghadri S, ...
  • Sharifi M, Yousefnia H, Zolghadri S, Bahrami-Samani A, Naderi M, ...
  • Masteri Farahani A, Maleki F, Sadeghzadeh N, Abediankenari S, Abedi ...
  • Lodhi NA, Park JY, Kim K, Hong MK, Kim YJ, ...
  • نمایش کامل مراجع